Search Results - "Selverian, Christopher N"

Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations by Dussupt, Vincent, Sankhala, Rajeshwer S., Mendez-Rivera, Letzibeth, Townsley, Samantha M., Schmidt, Fabian, Wieczorek, Lindsay, Lal, Kerri G., Donofrio, Gina C., Tran, Ursula, Jackson, Nathaniel D., Zaky, Weam I., Zemil, Michelle, Tritsch, Sarah R., Chen, Wei-Hung, Martinez, Elizabeth J., Ahmed, Aslaa, Choe, Misook, Chang, William C., Hajduczki, Agnes, Jian, Ningbo, Peterson, Caroline E., Rees, Phyllis A., Rutkowska, Magdalena, Slike, Bonnie M., Selverian, Christopher N., Swafford, Isabella, Teng, I-Ting, Thomas, Paul V., Zhou, Tongqing, Smith, Clayton J., Currier, Jeffrey R., Kwong, Peter D., Rolland, Morgane, Davidson, Edgar, Doranz, Benjamin J., Mores, Christopher N., Hatziioannou, Theodora, Reiley, William W., Bieniasz, Paul D., Paquin-Proulx, Dominic, Gromowski, Gregory D., Polonis, Victoria R., Michael, Nelson L., Modjarrad, Kayvon, Joyce, M. Gordon, Krebs, Shelly J.

“…Prevention of viral escape and increased coverage against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern require therapeutic…”
Get full text

An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer by Suryadevara, Naveenchandra, Shiakolas, Andrea R, VanBlargan, Laura A, Binshtein, Elad, Chen, Rita E, Case, James Brett, Kramer, Kevin J, Armstrong, Erica C, Myers, Luke, Trivette, Andrew, Gainza, Christopher, Nargi, Rachel S, Selverian, Christopher N, Davidson, Edgar, Doranz, Benjamin J, Diaz, Summer M, Handal, Laura S, Carnahan, Robert H, Diamond, Michael S, Georgiev, Ivelin S, Crowe, Jr, James E

“…The protective human antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) focuses on the spike (S) protein, which decorates the…”
Get full text

Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes by Chen, Elaine C., Gilchuk, Pavlo, Zost, Seth J., Ilinykh, Philipp A., Binshtein, Elad, Huang, Kai, Myers, Luke, Bonissone, Stefano, Day, Samuel, Kona, Chandrahaas R., Trivette, Andrew, Reidy, Joseph X., Sutton, Rachel E., Gainza, Christopher, Diaz, Summer, Williams, Jazmean K., Selverian, Christopher N., Davidson, Edgar, Saphire, Erica Ollmann, Doranz, Benjamin J., Castellana, Natalie, Bukreyev, Alexander, Carnahan, Robert H., Crowe, James E.

“…Understanding the human antibody response to emerging viral pathogens is key to epidemic preparedness. As the size of the B cell response to a…”
Get full text

Monkeypox Virus Infection Stimulates a More Robust and Durable Neutralizing Antibody Response Compared to Modified Vaccinia Virus Ankara Vaccination by Selverian, Christopher N, Monticelli, Stephanie R, Jaleta, Yakin M, Lasso, Gorka, DeMouth, Megan E, Meola, Annalisa, Berrigan, Jacob, Batchelor, Thomas G, Battini, Leandro, Guardado-Calvo, Pablo, Herbert, Andrew S, Chandran, Kartik, Meyerowitz, Eric, Miller, Emily Happy

“…Abstract Monkeypox virus (MPXV) has recently caused a global disease outbreak in humans. Differences in the neutralizing antibody response to vaccination…”
Get full text

MPXV Infection Stimulates a More Robust and Durable Neutralizing Antibody Response Compared to MVA-BN Vaccination by Selverian, Christopher N, Monticelli, Stephanie R, Jaleta, Yakin M, Lasso, Gorka, DeMouth, Megan E, Meola, Annalisa, Berrigan, Jacob, Batchelor, Thomas G, Battini, Leandro, Guardado-Calvo, Pablo, Herbert, Andrew S, Chandran, Kartik, Meyerowitz, Eric, Miller, Emily Happy

“…Monkeypox virus (MPXV) has recently caused a global disease outbreak in humans. Differences in the neutralizing antibody response to vaccination vs. MPXV…”
Get full text